TY - CHAP A1 - Susan E. Morgan A2 - Amber Finn A3 - Jessica Raley A4 - Wei Peng A5 - Aurora Occa A6 - Soroya Julian McFarlane A7 - Janice Krieger A8 - JoNell E. Potter ED1 - Milica Prostran Y1 - 2018-05-09 PY - 2018 T1 - Assessing Communication Practice during Clinical Trial Recruitment and Consent: The Clinical Trial Communication Inventory (CTCI) N2 - This book Clinical Trials in Vulnerable Populations has 12 chapters divided into 4 sections: Minority Patients, Women, Medically Compromised Patients and Clinical Trials. Contributing authors came from several countries, from Serbia to Turkey. The book was edited by Professor Milica Prostran MD, Ph.D., specialist in Clinical Pharmacology. The potential reader is shown a modern approach to clinical trials in vulnerable populations, from different points of view. The chapters deal at length and clarity with their topics. Finally, I believe, that this book I edited and reviewed with dedication will capture the attention of many readers, from medical students to practicing doctors and pharmacists. All of whom must consider this very important field of medicine: clinical trials in vulnerable patients. BT - Clinical Trials in Vulnerable Populations SP - Ch. 12 UR - https://doi.org/10.5772/intechopen.70192 DO - 10.5772/intechopen.70192 SN - 978-1-78923-201-1 PB - IntechOpen CY - Rijeka Y2 - 2022-01-19 ER -